메뉴 건너뛰기




Volumn 150, Issue 2-3, 2013, Pages 343-345

Issues in Selection of Instruments to Measure Negative Symptoms

Author keywords

Negative symptom measurement; Schizophrenia

Indexed keywords

ANHEDONIA; ANTISOCIAL BEHAVIOR; AWARENESS; BLUNTED AFFECT; BRIEF NEGATIVE SYMPTOM SCALE; CLINICAL ASSESSMENT INTERVIEW FOR NEGATIVE SYMPTOM; DISTRESS SYNDROME; FACIAL EXPRESSION; GESTURE; HUMAN; MARDER NEGATIVE FACTOR; MOTIVATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYMPTOM ASSESSMENT 16; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RECREATION; RELIABILITY; REVIEW; SCALE FOR ASSESSMENT OF NEGATIVE SYMPTOM; SOCIAL INTERACTION; STRUCTURED INTERVIEW;

EID: 84886233361     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.07.005     Document Type: Review
Times cited : (50)

References (16)
  • 3
    • 80052152783 scopus 로고    scopus 로고
    • Training for assessment of negative symptoms of schizophrenia across languages and cultures: comparison of the NSA-16 with the PANSS Negative Subscale and Negative Symptom factor
    • Daniel D.G., Alphs L., Cazorla P., Bartko J.J., Panagides J. Training for assessment of negative symptoms of schizophrenia across languages and cultures: comparison of the NSA-16 with the PANSS Negative Subscale and Negative Symptom factor. Clin. Schizophr. Relat. Psychoses 2011, 5:87-94.
    • (2011) Clin. Schizophr. Relat. Psychoses , vol.5 , pp. 87-94
    • Daniel, D.G.1    Alphs, L.2    Cazorla, P.3    Bartko, J.J.4    Panagides, J.5
  • 5
    • 78249287537 scopus 로고    scopus 로고
    • Initial development and preliminary validation of a new negative symptom measure: The Clinical Assessment Interview for Negative Symptoms (CAINS)
    • Forbes C., Blanchard J.J., Bennett M., Horan W.P. Initial development and preliminary validation of a new negative symptom measure: The Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr. Res. 2010, 124:36-42.
    • (2010) Schizophr. Res. , vol.124 , pp. 36-42
    • Forbes, C.1    Blanchard, J.J.2    Bennett, M.3    Horan, W.P.4
  • 7
    • 1942440555 scopus 로고    scopus 로고
    • Validity of symptom assessment in psychotic disorders: information variance across different sources of history
    • Ho Beng-Choon, Flaum M., Hubbard W., Arndt S., Andreasen N.C. Validity of symptom assessment in psychotic disorders: information variance across different sources of history. Schizophr. Res. 2004, 68:299-307.
    • (2004) Schizophr. Res. , vol.68 , pp. 299-307
    • Ho, B.-C.1    Flaum, M.2    Hubbard, W.3    Arndt, S.4    Andreasen, N.C.5
  • 8
    • 80054066105 scopus 로고    scopus 로고
    • Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS)
    • Horan W.P., Kring A.M., Gur R.E., Reise S.P., Blanchard J.J. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr. Res. 2011, 132:140-145.
    • (2011) Schizophr. Res. , vol.132 , pp. 140-145
    • Horan, W.P.1    Kring, A.M.2    Gur, R.E.3    Reise, S.P.4    Blanchard, J.J.5
  • 10
    • 33645226430 scopus 로고    scopus 로고
    • The NIMH-MATRICS consensus statement on negative symptoms
    • Kirkpatrick B., Fenton W.S., et al. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32(2):214-219.
    • (2006) Schizophr. Bull. , vol.32 , Issue.2 , pp. 214-219
    • Kirkpatrick, B.1    Fenton, W.S.2
  • 12
    • 84873396022 scopus 로고    scopus 로고
    • Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation
    • Kring A.M., Gur R.E., Blanchard J.J., Horan W.P., Reise S.P. Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation. Am. J. Psychiatry 2013, 170(2):165-172. (Feb 1).
    • (2013) Am. J. Psychiatry , vol.170 , Issue.2 FEB 1 , pp. 165-172
    • Kring, A.M.1    Gur, R.E.2    Blanchard, J.J.3    Horan, W.P.4    Reise, S.P.5
  • 13
    • 34548682554 scopus 로고    scopus 로고
    • Revisiting the 5 Dimensions of the Positive and Negative Syndrome Scale
    • Levine S.Z., Rabinowitz J. Revisiting the 5 Dimensions of the Positive and Negative Syndrome Scale. J. Clin. Psychopharmacol. 2007, 27(5):431-436.
    • (2007) J. Clin. Psychopharmacol. , vol.27 , Issue.5 , pp. 431-436
    • Levine, S.Z.1    Rabinowitz, J.2
  • 14
    • 79952141373 scopus 로고    scopus 로고
    • Methodological issues in negative symptom trials
    • Marder S.R., Daniel D.G., et al. Methodological issues in negative symptom trials. Schizophr. Bull. 2011, 37(2):250-254.
    • (2011) Schizophr. Bull. , vol.37 , Issue.2 , pp. 250-254
    • Marder, S.R.1    Daniel, D.G.2
  • 15
    • 84869864467 scopus 로고    scopus 로고
    • Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale
    • Strauss G.P., Keller W.R., Buchanan R.W., et al. Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale. Schizophr. Res 2012, 10.1016/j.schres.2012.10.012.
    • (2012) Schizophr. Res
    • Strauss, G.P.1    Keller, W.R.2    Buchanan, R.W.3
  • 16
    • 84869876105 scopus 로고    scopus 로고
    • Factor structure of the brief negative symptom scale
    • Strauss G.P., Hong L.E., Gold J.M., et al. Factor structure of the brief negative symptom scale. Schizophr. Res 2012, 10.1016/j.schres.2012.09.007.
    • (2012) Schizophr. Res
    • Strauss, G.P.1    Hong, L.E.2    Gold, J.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.